Blood Biomarkers for Neurodegeneration

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

198 papers

Showing 97-108 of total 198 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedDirectly related

Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer's Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging Outcomes.

Hey JA; Abushakra S; Power A; Watson D; Porsteinsson A; Sabbagh M; MacSweeney E; Cohen S; Boada M; Doraiswamy PM; Elahi FM; Rissman RA; Liang E; Flint S; Hristova E; Kesslak P; McLaine R; Albayrak A; Schaefer JF; Yu JY; Tolar L; Tolar M

Jan 1, 2026Drugs

2026PubMedSupporting evidence

Plasma neurofilament light for early differentiation of multiple system atrophy from Parkinson disease.

Yu Z; Zheng Y; Kou W; Cai H; Li S; Wu J; Yang C; Zhu B; Liu G; Wang Y; Tian H; Zhang X; Zhou Y; Liu X; Chang Y; Chen Z; Mao W; Feng T

Jan 1, 2026EBioMedicine

2026PubMedDirectly related

Cerebrospinal fluid homocysteine, but not plasma homocysteine, is associated with markers of tau pathology and neurodegeneration.

Lee JH; Won GH; Lee SI; Shin CJ; Son JW; Kim S; Ju G; Chung S; Jung JH; Alzheimer's Disease Neuroimaging Initiative

Jan 1, 2026Journal of Alzheimer's disease : JAD

2026PubMedSupporting evidence

Investigation of neuroprotective and antiapoptotic effects of rosmarinic acid in an in vitro Alzheimer's disease model.

Şen A; Eroğlu Güneş C; Dursun EN; Kurar E; Kutlu S

Jan 1, 2026Iranian journal of basic medical sciences

2026PubMedSupporting evidence

Lecanemab in symptomatic PSEN1 p.Met233Val early-onset Alzheimer's disease: Neuroimaging safety, regional amyloid-PET dynamics, and longitudinal plasma biomarkers.

Noh MY; Sung W; Kim H; Son B; Kim YE; Choi YY; Holtzman DM; Kim SH

Jan 1, 2026Alzheimer's & dementia (Amsterdam, Netherlands)

2026PubMedDirectly related

Acute total sleep deprivation transiently increases plasma total tau but not plasma P-tau181 in healthy adults.

Zhao B; Wei M; Shang S; Gao L; Wei S; Dang L; Liu J; Chen C; Li Y; Wang J; Gao F; Qu Q

Jan 1, 2026Frontiers in aging neuroscience

2026PubMedDirectly related

Glymphatic dysfunction in cerebellar neurodegeneration: mechanistic insights and emerging clinical implications.

Rodriguez PF; Rivas LMF; Canino GR

Jan 1, 2026Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

2026PubMedDirectly related

Nanotechnology-enabled delivery of bioactive compounds for neuroprotection in Parkinson's disease: mechanisms and future directions.

Gaur P; Bisht PR; Lal Gupta S

Jan 1, 2026Journal of biomaterials science. Polymer edition

2026PubMedDirectly related

Methodological insights and clinical outcomes in ALS and FTLD: lessons from the SPIN cohort.

Carbayo Á; Turon-Sans J; Alcolea D; Cortés-Vicente E; Cabezas-Torres M; Alvarez-Sanchez E; Muñoz L; Rubio-Guerra S; García-Castro J; Selma-González J; Bernal S; Gonzalez-Quereda L; Bejanin A; Aranha MR; Santos-Santos M; Belbin O; Vesperinas-Castro A; Collet-Vidiella R; Caballero-Ávila M; Llansó L; Querol L; Lleó A; Fortea J; Gelpí E; Dols-Icardo O; Illán-Gala I; Rojas-Garcia R

Jan 1, 2026Alzheimer's & dementia : the journal of the Alzheimer's Association

2026PubMedSupporting evidence

Traumatic Brain Injury: Multi-Omics Insights into Brain Aging, Neurodegeneration, and Precision Therapeutics.

Shafie A; Ashour AA; Alhujaily MM; Anjum F; Akhtar F; Hassan MI

Jan 1, 2026Ageing research reviews

2026PubMedDirectly related

Glycation at the Gate: A Brain Endothelial Glycocalyx Model and Therapeutic Roadmap for Alzheimer's Disease.

Tarawneh R

Jan 1, 2026Biomedicines

2026PubMedDirectly related

Association of Vitamin D Status with Neurobiological Biomarkers in Healthy Elderly Population.

Sanoop E; Kumarchandra R; Madhurya M; Cherian A

Jan 1, 2026La Clinica terapeutica